Skip to main content
Top
Published in: Molecular Diagnosis & Therapy 1/2006

01-01-2006 | Original Research Article

Brushing of Oral Mucosa for Diagnosis of HPV Infection in Patients with Potentially Malignant and Malignant Oral Lesions

Authors: Lucia Giovannelli, Giuseppina Campisi, Giuseppe Colella, Giuseppina Capra, Chiara Di Liberto, Maria Pia Caleca, Domenica Matranga, Matteo D’Angelo, Lorenzo Lo Muzio, Prof. Pietro Ammatuna

Published in: Molecular Diagnosis & Therapy | Issue 1/2006

Login to get access

Abstract

Introduction: Adequate brushing of oral mucosa is important for accurate human papillomavirus (HPV) detection in potentially malignant (oral leukoplakia [OL], oral lichen planus [OLP]) and malignant (oral squamous cell carcinoma [OSCC]) lesions. Since various factors may limit the adequacy of oral brushing and, consequently, the accuracy of HPV detection, modified sampling procedures should be evaluated for their effect on HPV frequency and/or types detected.
Aim: To compare the HPV frequency in samples obtained by brushing the lesion site with the frequency in samples obtained by brushing an apparently normal adjacent site. The correlation between HPV frequency and keratinization of the site affected by the lesion, as well as sociodemographic variables (age, sex, smoking and drinking habits), was also examined.
Methods: HPV DNA was detected in brushing samples from 50 patients with OL, 49 with OLP, and 17 with OSCC. Polymerase chain reaction (PCR) amplification was performed by MY09/MY11 and GP05+/GP06+ primers; the HPV type was identified by DNA sequencing and a reverse hybridization (line probe) assay. Data were analyzed by the Z test, the Fisher’s exact test, the chi-square test, odds ratio (OR), and a logistic regression model.
Results: HPV DNA was detected in 22% of samples from lesion sites and in 16% of samples from adjacent sites (p = 0.22) in patients with OL, in 24.5% and 22.4% of samples from lesion and adjacent sites, respectively, in patients with OLP (p = 0.40), and in 35.3% and 41.2% of samples from lesion and adjacent sites, respectively, in patients with OSCC (p = 0.36). Lesions adjacent to HPV-positive normal sites had an increased rate of HPV detection (OR = 30; 95% CI 9.57, 94.1). HPV-18 was the most frequent genotype, followed by HPV-6, -16, -33, and -53. HPV prevalence was reduced in lesions at keratinized sites (14.5%) compared with non-keratinized sites (34.4%; p = 0.007; OR = 0.32; 95% CI 0.13, 0.81).
Discussion: In patients with OL, OLP, or OSCC, a high prevalence of HPV infection was shown in apparently normal sites adjacent to lesion sites infected by HPV. The lower HPV frequency in lesions at keratinized sites suggests that HPV detection by lesion brushing is affected by keratinization. The keratinized epithelium may be less susceptible to HPV infection or, alternatively, the highly proliferative activity in non-keratinized sites may predispose to HPV infection.
Conclusion: Results from this study indicate that taking samples from normal sites adjacent to oral lesions may be of value in HPV detection, particularly when the lesions are located at keratinized sites. This sampling procedure may allow more accurate diagnosis of HPV infection compared with sampling only the lesion site, and may also represent a reliable method to investigate the biological characteristics of HPV infection and related oral carcinogenesis.
Literature
1.
go back to reference Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000 May 3; 92(9): 709–20PubMedCrossRef Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000 May 3; 92(9): 709–20PubMedCrossRef
2.
go back to reference Giovannelli L, Campisi G, Lama A, et al. Human papillomavirus DNA in oral mucosal lesions. J Infect Dis 2002 Mar 15; 185(6): 833–6PubMedCrossRef Giovannelli L, Campisi G, Lama A, et al. Human papillomavirus DNA in oral mucosal lesions. J Infect Dis 2002 Mar 15; 185(6): 833–6PubMedCrossRef
3.
go back to reference Ostwald C, Rutsatz K, Schweder J, et al. Human papillomavirus 6/11,16 and 18 in oral carcinomas and benign oral lesions. Med Microbiol Immunol (Berl) 2003 Aug; 192(3): 145–8CrossRef Ostwald C, Rutsatz K, Schweder J, et al. Human papillomavirus 6/11,16 and 18 in oral carcinomas and benign oral lesions. Med Microbiol Immunol (Berl) 2003 Aug; 192(3): 145–8CrossRef
4.
go back to reference zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000 May 3; 92(9): 690–8PubMedCrossRef zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000 May 3; 92(9): 690–8PubMedCrossRef
5.
go back to reference Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 Jun; 91(6): 622–35PubMedCrossRef Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 Jun; 91(6): 622–35PubMedCrossRef
6.
go back to reference Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003 Dec 3; 95(23): 1772–83PubMedCrossRef Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003 Dec 3; 95(23): 1772–83PubMedCrossRef
7.
go back to reference Campisi G, Giovannelli L, Arico P, et al. HPV DNA in clinically different variants of oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 Dec; 98(6): 705–11PubMedCrossRef Campisi G, Giovannelli L, Arico P, et al. HPV DNA in clinically different variants of oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004 Dec; 98(6): 705–11PubMedCrossRef
8.
go back to reference Ostwald C, Muller P, Barten M, et al. Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosa. J Oral Pathol Med 1994 May; 23(5): 220–5PubMedCrossRef Ostwald C, Muller P, Barten M, et al. Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosa. J Oral Pathol Med 1994 May; 23(5): 220–5PubMedCrossRef
9.
go back to reference Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004 Mar 17; 96(6): 449–55PubMedCrossRef Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004 Mar 17; 96(6): 449–55PubMedCrossRef
10.
go back to reference Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998 Nov 4; 90(21): 1626–36PubMedCrossRef Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998 Nov 4; 90(21): 1626–36PubMedCrossRef
11.
go back to reference Califano J, van der Riet P, Westra P, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996 Jun; 56(ll): 2488–92PubMed Califano J, van der Riet P, Westra P, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996 Jun; 56(ll): 2488–92PubMed
12.
go back to reference Ogden GR, Nairn A, Franks J, et al. Do gelatin-coated slides increase cellular retention in oral exfoliative cytology? Acta Cytol 1991 Mar–Apr; 35(2): 186–8PubMed Ogden GR, Nairn A, Franks J, et al. Do gelatin-coated slides increase cellular retention in oral exfoliative cytology? Acta Cytol 1991 Mar–Apr; 35(2): 186–8PubMed
13.
go back to reference Winning TA, Townsend GC. Oral mucosal embryology and histology. Clin Dermatol 2000 Sep–Oct; 18(5): 499–511PubMedCrossRef Winning TA, Townsend GC. Oral mucosal embryology and histology. Clin Dermatol 2000 Sep–Oct; 18(5): 499–511PubMedCrossRef
14.
go back to reference Resnick RM, Cornelissen MT, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990 Sep 19; 82(18): 1477–84PubMedCrossRef Resnick RM, Cornelissen MT, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990 Sep 19; 82(18): 1477–84PubMedCrossRef
15.
16.
go back to reference Giovannelli L, Lama A, Capra G, et al. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay. J Clin Microbiol 2004 Aug; 42(8): 3861–4PubMedCrossRef Giovannelli L, Lama A, Capra G, et al. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay. J Clin Microbiol 2004 Aug; 42(8): 3861–4PubMedCrossRef
17.
go back to reference Walter H, Matsumoto H, Danker-Hopfe H, et al. GM and KM allotypes in nine population samples of Sicily. Ann Hum Biol 1997; 24: 419–26PubMedCrossRef Walter H, Matsumoto H, Danker-Hopfe H, et al. GM and KM allotypes in nine population samples of Sicily. Ann Hum Biol 1997; 24: 419–26PubMedCrossRef
18.
go back to reference Aggelopoulou EP, Skarlos D, Papadimitriou C, et al. Human papilloma virus DNA detection in oral lesions in the Greek population. Anticancer Res 1999; 19: 1391–5PubMed Aggelopoulou EP, Skarlos D, Papadimitriou C, et al. Human papilloma virus DNA detection in oral lesions in the Greek population. Anticancer Res 1999; 19: 1391–5PubMed
19.
go back to reference Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001 Dec 1; 92(11): 2875–84PubMedCrossRef Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001 Dec 1; 92(11): 2875–84PubMedCrossRef
20.
go back to reference Koppikar P, deVilliers EM, Mulherkar R. Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 2005 Mar 1; 113(6): 946–50PubMedCrossRef Koppikar P, deVilliers EM, Mulherkar R. Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 2005 Mar 1; 113(6): 946–50PubMedCrossRef
21.
go back to reference Ogden GR, Cowpe JG, Green M. Cytobrush and wooden spatula for oral exfoliative cytology: a comparison. Acta Cytol 1992 Sep–Oct; 36(5): 706–10PubMed Ogden GR, Cowpe JG, Green M. Cytobrush and wooden spatula for oral exfoliative cytology: a comparison. Acta Cytol 1992 Sep–Oct; 36(5): 706–10PubMed
22.
go back to reference Lawton G, Thomas S, Schonrock J, et al. Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. J Oral Pathol Med 1992 Jul; 21(6): 265–9PubMedCrossRef Lawton G, Thomas S, Schonrock J, et al. Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. J Oral Pathol Med 1992 Jul; 21(6): 265–9PubMedCrossRef
23.
go back to reference Jalal H, Sanders CM, Prime SS, et al. Detection of human papilloma virus type 16 DNA in oral squames from normal young adults. J Oral Pathol Med 1992 Nov; 21(10): 465–70PubMedCrossRef Jalal H, Sanders CM, Prime SS, et al. Detection of human papilloma virus type 16 DNA in oral squames from normal young adults. J Oral Pathol Med 1992 Nov; 21(10): 465–70PubMedCrossRef
24.
go back to reference Mashberg A. Clinical features of oral malignancy in relation to prognosis. Iowa City (IA): University of Iowa, 1980 Mashberg A. Clinical features of oral malignancy in relation to prognosis. Iowa City (IA): University of Iowa, 1980
25.
go back to reference Squier CA, Kremer MJ. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001; (29): 7-15 Squier CA, Kremer MJ. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001; (29): 7-15
26.
go back to reference Thomson PJ, Potten CS, Appleton DR. In vitro labelling studies and the measurement of epithelial cell proliferative activity in the human oral cavity. Arch Oral Biol 2001 Dec; 46(12): 1157–64PubMedCrossRef Thomson PJ, Potten CS, Appleton DR. In vitro labelling studies and the measurement of epithelial cell proliferative activity in the human oral cavity. Arch Oral Biol 2001 Dec; 46(12): 1157–64PubMedCrossRef
27.
go back to reference Thomson PJ, Potten CS, Appleton DR. Mapping dynamic epithelial cell proliferative activity within the oral cavity of man: a new insight into carcinogenesis? Br J Oral Maxillofac Surg 1999 Oct; 37(5): 377–83PubMedCrossRef Thomson PJ, Potten CS, Appleton DR. Mapping dynamic epithelial cell proliferative activity within the oral cavity of man: a new insight into carcinogenesis? Br J Oral Maxillofac Surg 1999 Oct; 37(5): 377–83PubMedCrossRef
28.
go back to reference zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002 May; 2(5): 342–50PubMedCrossRef zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002 May; 2(5): 342–50PubMedCrossRef
Metadata
Title
Brushing of Oral Mucosa for Diagnosis of HPV Infection in Patients with Potentially Malignant and Malignant Oral Lesions
Authors
Lucia Giovannelli
Giuseppina Campisi
Giuseppe Colella
Giuseppina Capra
Chiara Di Liberto
Maria Pia Caleca
Domenica Matranga
Matteo D’Angelo
Lorenzo Lo Muzio
Prof. Pietro Ammatuna
Publication date
01-01-2006
Publisher
Springer International Publishing
Published in
Molecular Diagnosis & Therapy / Issue 1/2006
Print ISSN: 1177-1062
Electronic ISSN: 1179-2000
DOI
https://doi.org/10.1007/BF03256442

Other articles of this Issue 1/2006

Molecular Diagnosis & Therapy 1/2006 Go to the issue

Adis Diagnostic Profile

T-SPOT™.TB

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.